Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01743976 · ClinicalTrials.gov registry record · Phase 4
Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
A Phase 4 study, sponsored by Wake Forest University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT01743976 is a Phase 4 study that was terminated before completion, run by Wake Forest University. The registered enrollment target is 5 participants.
The verdict
NCT01743976, a Phase 4 study, was terminated before completion, sponsored by Wake Forest University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
Based on laboratory studies, donepezil will improve pain relief more than placebo in patients with chronic neuropathic pain who are currently taking gabapentin or pregabalin.
Interventions
- DRUG Placebo
- DRUG Donepezil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-10-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01743976
The ClinicalTrials.gov registry entry for NCT01743976 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01743976 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01743976 about?
NCT01743976 is a clinical study titled "Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain". Based on laboratory studies, donepezil will improve pain relief more than placebo in patients with chronic neuropathic pain who are currently taking gabapentin or pregabalin.
What is the current status of trial NCT01743976?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2012-12. Estimated completion is 2013-10-23.
What interventions are being tested in trial NCT01743976?
The interventions under investigation include: Placebo (DRUG), Donepezil (DRUG).
Who is sponsoring clinical trial NCT01743976?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.